Meta-analysis of risk factors for cardiovascular disease in patients with rheumatoid arthritis

被引:0
|
作者
Lyu, Qian [1 ]
Ma, Linxiao [1 ,2 ]
Liu, Huijie [1 ]
Wang, Jihong [1 ]
机构
[1] Nanjing Med Univ, Peoples Hosp Lianyungang 1, Dept Rheumatol, Affiliated Hosp 1,Kangda Coll, Lianyungang, Peoples R China
[2] Nanjing Med Univ, Peoples Hosp Lianyungang 1, Dept Rheumatol, Affiliated Hosp 1,Kangda Coll, Lianyungang 222000, Peoples R China
关键词
cardiovascular disease; rheumatoid arthritis; risk factors; EVENTS;
D O I
10.1097/MD.0000000000035912
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background:Cardiovascular disease (CVD) is a common complication of rheumatoid arthritis (RA). We aimed to explore the risk factors for cardiovascular disease in patients with rheumatoid arthritis and provide a scientific basis on effective prevention and treatments for CVD in RA patients.Methods:We searched for a combination of the subject words and free words involved arthritis, rheumatoid, CVD, heart disease, vascular disease, risk factors, etc. from China Knowledge Network, Wanfang, Vip, China Biomedical Literature Database, Pubmed, Embase, Web of Science, Cochrane and other databases for documents published in public in 2000-October 2022.RevMan 5.3 and Stata14.0 analysis software was used to perform a meta-analysis of case-control and cohort studies on risk factors of CVDs in patients with RA published from 2000 to 2022.The Egger method was used to determine whether there was publication bias.Results:Seventeen pieces of literature were included in this meta-analysis. We explored the associations between CVD and different clinical characters such as DAS28 score, rheumatoid factor, triglyceride, age, sex, C-reactive protein, total cholesterol (TC), hypertension, and D dimer. High serum levels of C-reactive protein, TC, and D-dimer, as well as hypertension, are the main risk factors for CVD in patients with RA. The OR and 95% CI of C-reactive protein were 2.06 (1.91-2.23), RR and 95% CI of TC were 1.7 (1.49-1.93), RR and 95% CI of hypertension were 3.58 (2.37-5.40), as well as OR and 95% CI of D dimer were 2.83 (1.48-5.40).Our results performed by the meta-analysis were reliable, with low publication bias existed.Conclusion:C-reactive protein, TC, hypertension, and D dimer are the main risk factors for CVD in patients with RA. No protective factors were found.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Incidence and risk factors for vertebral fracture in rheumatoid arthritis: an update meta-analysis
    Liu, Yang
    Jiang, Jun
    Mo, Minmin
    Sun, Xiaohong
    Yu, Kailong
    CLINICAL RHEUMATOLOGY, 2022, 41 (05) : 1313 - 1322
  • [42] Incidence and risk factors for vertebral fracture in rheumatoid arthritis: an update meta-analysis
    Yang Liu
    Jun Jiang
    Minmin Mo
    Xiaohong Sun
    Kailong Yu
    Clinical Rheumatology, 2022, 41 : 1313 - 1322
  • [43] Diabetes mellitus risk factors in rheumatoid arthritis: a systematic review and meta-analysis
    Jiang, P.
    Li, H.
    Li, X.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (01) : 115 - 121
  • [44] The management of cardiovascular disease risk in patients with rheumatoid arthritis
    Ahmed, Omar
    Krishnamurthy, Vinodh
    Kaba, Riyaz A.
    Tahir, Hasan
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (08) : 947 - 958
  • [45] Cardiovascular disease in rheumatoid arthritis: medications and risk factors in China
    Chun Li
    X. R. Wang
    H. J. Ji
    X. Y. Zhang
    X. F. Li
    L. Z. Wang
    C. H. Wang
    Y. F. Wang
    Rong Yang
    G. C. Wang
    Xin Lu
    Ping Zhu
    L. N. Chen
    H. T. Jin
    J. T. Liu
    X. Y. Liu
    Lin Sun
    H. Y. Chen
    Ping Wei
    J. X. Wang
    L. F. Cui
    Rong Shu
    B. L. Liu
    Z. L. Zhang
    G. T. Li
    Z. B. Li
    Jing Yang
    J. F. Li
    Bin Jia
    F. X. Zhang
    J. M. Tao
    S. L. Han
    J. Y. Lin
    M. Q. Wei
    X. M. Liu
    Dan Ke
    S. X. Hu
    Cong Ye
    X. Y. Yang
    Hao Li
    C. B. Huang
    Ming Gao
    Bei Lai
    X. F. Li
    L. J. Song
    Yi Wang
    X. Y. Wang
    Y. D. Tang
    Yin Su
    Rong Mu
    Clinical Rheumatology, 2017, 36 : 1023 - 1029
  • [46] Cardiovascular disease in rheumatoid arthritis: medications and risk factors in China
    Li, Chun
    Wang, X. R.
    Ji, H. J.
    Zhang, X. Y.
    Li, X. F.
    Wang, L. Z.
    Wang, C. H.
    Wang, Y. F.
    Yang, Rong
    Wang, G. C.
    Lu, Xin
    Zhu, Ping
    Chen, L. N.
    Jin, H. T.
    Liu, J. T.
    Liu, X. Y.
    Sun, Lin
    Chen, H. Y.
    Wei, Ping
    Wang, J. X.
    Cui, L. F.
    Shu, Rong
    Liu, B. L.
    Zhang, Z. L.
    Li, G. T.
    Li, Z. B.
    Yang, Jing
    Li, J. F.
    Jia, Bin
    Zhang, F. X.
    Tao, J. M.
    Han, S. L.
    Lin, J. Y.
    Wei, M. Q.
    Liu, X. M.
    Ke, Dan
    Hu, S. X.
    Ye, Cong
    Yang, X. Y.
    Li, Hao
    Huang, C. B.
    Gao, Ming
    Lai, Bei
    Li, X. F.
    Song, L. J.
    Wang, Yi
    Wang, X. Y.
    Tang, Y. D.
    Su, Yin
    Mu, Rong
    CLINICAL RHEUMATOLOGY, 2017, 36 (05) : 1023 - 1029
  • [47] Turmeric reduces cardiovascular disease risk factors in rheumatoid arthritis
    Frye, J. B.
    Timmermann, B. N.
    Funk, J. L.
    PLANTA MEDICA, 2008, 74 (09) : 1182 - 1182
  • [48] Cardiovascular disease in patients with rheumatoid arthritis: impact of classic and disease-specific risk factors
    Cavalli, Giulio
    Favalli, Ennio Giulio
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6
  • [49] CARDIOVASCULAR RISK FACTORS IN RHEUMATOID ARTHRITIS
    Chico Capote, Araceli
    Uguna Sari, Franklin
    Hidalgo Costa, Tania
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 20 - 20
  • [50] Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?
    Gonzalez, A.
    Kremers, H. Maradit
    Crowson, C. S.
    Ballman, K. V.
    Roger, V. L.
    Jacobsen, S. J.
    O'Fallon, W. M.
    Gabriel, S. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (01) : 64 - 69